{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:02:08Z","timestamp":1790344928588,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2026.100208","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:45:39Z","timestamp":1783604739000},"page":"100208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The epidemiology of inflammatory rheumatic diseases in Germany in a European context: a systematic review to support workforce planning"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-0294","authenticated-orcid":false,"given":"Katinka","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8726-3293","authenticated-orcid":false,"given":"Carlo A.G.","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-022X","authenticated-orcid":false,"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-2728","authenticated-orcid":false,"given":"Johanna","family":"Callhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0001","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3899\/jrheum.220300","article-title":"The challenge of addressing the rheumatology workforce shortage","volume":"49","author":"Miloslavsky","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ero.2026.100208_bib0002","series-title":"Rheumatology workforce: a crisis in numbers [Internet]","year":"2021"},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0003","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00393-025-01720-1","article-title":"Quo vadis rheumatologische Versorgung in Deutschland? Neue Fach\u00e4rztezahlen zum 31.12.2024 [Quo vadis rheumatology care in Germany? New figures on specialists as of 31.12.2024]","volume":"85","author":"Albrecht","year":"2026","journal-title":"Z Rheumatol."},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00393-022-01302-5","article-title":"Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany","volume":"83","author":"Albrecht","year":"2024","journal-title":"Z Rheumatol."},{"issue":"10391","key":"10.1016\/j.ero.2026.100208_bib0005","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0006","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"26","key":"10.1016\/j.ero.2026.100208_bib0007","article-title":"Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project","volume":"S0003-4967","author":"Molt\u00f3","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0009","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0010","first-page":"263","article-title":"Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature","volume":"36","author":"Bohn","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.ero.2026.100208_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0012","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3899\/jrheum.200367","article-title":"The prevalence of rheumatoid arthritis: a systematic review of population-based studies","volume":"48","author":"Almutairi","year":"2021","journal-title":"J Rheumatol."},{"issue":"9","key":"10.1016\/j.ero.2026.100208_bib0013","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol."},{"issue":"12","key":"10.1016\/j.ero.2026.100208_bib0014","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/rheumatology\/keae198","article-title":"The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis","volume":"63","author":"Lembke","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.100208_bib0015","unstructured":"Statistisches Bundesamt (destatis). Population: federal states, reference date, years of age [Internet]. [cited 2025 Jul 14]. Available from: https:\/\/www-genesis.destatis.de\/datenbank\/online\/statistic\/12411\/table\/12411-0012\/search\/s\/YmV2JUMzJUI2bGtlcnVuZw=="},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0017","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jdv.20489","article-title":"Epidemiology and treatment of Adamantiades-Behcet\u2019s disease in Germany: a healthcare claims database study","volume":"39","author":"Zouboulis","year":"2025","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"11","key":"10.1016\/j.ero.2026.100208_bib0018","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1093\/rheumatology\/keaf367","article-title":"Frequency, diagnosis, and management of polymyalgia rheumatica in Germany-database analysis of medical insurance data","volume":"64","author":"Schmidt","year":"2025","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100208_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X261439725","article-title":"Frequency, diagnosis, and pharmacological treatment of giant cell arteritis in Germany: database analysis of medical insurance data","volume":"18","author":"Schmidt","year":"2026","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40744-024-00735-5","article-title":"Real-world prevalence, incidence and management of systemic lupus erythematosus in Germany: a retrospective claims data analysis","volume":"12","author":"Alexander","year":"2025","journal-title":"Rheumatol Ther."},{"key":"10.1016\/j.ero.2026.100208_bib0021","series-title":"Entwicklung der Pr\u00e4valenz diagnostizierter Autoimmunerkrankungen im Zeitraum 2012\u20132022 [Time trends in the prevalence of diagnosed autoimmune diseases in the period of 2012 to 2022] [Internet]. Versorgungsatlas-Bericht Nr 24\/05","author":"Akmatov","year":"2024"},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s43999-025-00061-5","article-title":"Sex-specific and regional differences in the prevalence of diagnosed autoimmune diseases in Germany, 2022","volume":"4","author":"Akmatov","year":"2025","journal-title":"Res Health Serv Reg."},{"key":"10.1016\/j.ero.2026.100208_bib0023","unstructured":"Wissenschaftliches Institut der AOK (WIdO). Gesundheitsatlas Deutschland, Rheumatoide Arthritis, Anteil erkrankter Menschen (1-Jahres-Pr\u00e4valenz) in Prozent, Stand 2023 [Health Atlas Germany, Rheumatoid arthritis, percentage of affected individuals (1-year prevalence), as of 2023] [Internet]. [cited 2025 Nov 7]. Available from: https:\/\/www.gesundheitsatlas-deutschland.de"},{"issue":"7","key":"10.1016\/j.ero.2026.100208_bib0024","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00393-023-01459-7","volume":"83","author":"Riemekasten","year":"2024","journal-title":"Z Rheumatol."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00393-022-01306-1","article-title":"Chronische Entz\u00fcndungserkrankungen in Deutschland: Eine Querschnittanalyse \u00fcber Begleiterkrankungen und Arzneimitteleinsatz [Immune-mediated inflammatory diseases in Germany: a cross-sectional analysis of comorbidities and pharmacotherapy]","volume":"83","author":"Leipe","year":"2024","journal-title":"Z Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0026","first-page":"45","article-title":"Prevalence of psoriasis and psoriatic arthritis in Germany - analysis of claims data","volume":"22","author":"Hagenstr\u00f6m","year":"2024","journal-title":"J Dtsch Dermatol Ges."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s42466-022-00226-4","article-title":"Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019","volume":"4","author":"Pawlitzki","year":"2022","journal-title":"Neurol Res Pract."},{"issue":"24","key":"10.1016\/j.ero.2026.100208_bib0028","first-page":"411","article-title":"Polymyalgia Rheumatica","volume":"119","author":"Colombo","year":"2022","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0029","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40744-021-00277-0","article-title":"The burden of systemic lupus erythematosus in germany: incidence, prevalence, and healthcare resource utilization","volume":"8","author":"Schwarting","year":"2021","journal-title":"Rheumatol Ther."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-1192-4628","article-title":"Pr\u00e4valenz der Rheumatoiden Arthritis in Deutschland: Analyse von L\u00e4ngsschnittdaten der Gesetzlichen Krankenversicherung [Prevalence of rheumatoid arthritis in Germany: analysis of longitudinal data of statutory health insurance]","volume":"83","author":"Kienitz","year":"2021","journal-title":"Gesundheitswesen"},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0031","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1093\/rheumatology\/keaa924","article-title":"New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study","volume":"60","author":"Hellmich","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0032","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12325-020-01522-8","article-title":"Epidemiology and treatment of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in Germany: a real-world evidence study","volume":"38","author":"Grellmann","year":"2021","journal-title":"Adv Ther."},{"issue":"4","key":"10.1016\/j.ero.2026.100208_bib0033","first-page":"78","article-title":"Comorbidity and health care utilisation in persons with Sjogren's syndrome: a claims data analysis","volume":"38 Suppl 126","author":"Albrecht","year":"2020","journal-title":"Clin Exp Rheumatol."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0034","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00393-017-0381-6","volume":"77","author":"Strahl","year":"2018","journal-title":"Z Rheumatol."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0035","first-page":"285","article-title":"Analysis of pharmaceutical care in patients with psoriatic arthritis using statutory health insurance data","volume":"16","author":"Sondermann","year":"2018","journal-title":"J Dtsch Dermatol Ges."},{"issue":"11","key":"10.1016\/j.ero.2026.100208_bib0036","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00296-018-4124-z","article-title":"Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis","volume":"38","author":"Kr\u00fcger","year":"2018","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.ero.2026.100208_bib0037","author":"Steffen","year":"2017"},{"issue":"8","key":"10.1016\/j.ero.2026.100208_bib0038","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00393-016-0088-0","volume":"75","author":"Hense","year":"2016","journal-title":"Z Rheumatol."},{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0039","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00296-024-05591-8","article-title":"Rheumatoid arthritis epidemiology: a nationwide study in Poland","volume":"44","author":"Krajewska-W\u0142odarczyk","year":"2024","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.ero.2026.100208_bib0040","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data","volume":"23","author":"Scott","year":"2022","journal-title":"Lancet Reg Health Eur."},{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0041","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/03009742.2021.1957557","article-title":"Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study","volume":"51","author":"Soussi","year":"2022","journal-title":"Scand J Rheumatol"},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0042","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ard.2025.05.1022","article-title":"Is there an increase in the prevalence and incidence rates of rheumatoid arthritis in Catalonia, Spain: a population-based study (2006-2021) [abstract POS0643]","volume":"84","author":"G\u00f3mez-Puerta","year":"2025","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76511-6","article-title":"The prevalence of rheumatoid arthritis in Spain","volume":"10","author":"Silva-Fern\u00e1ndez","year":"2020","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/j.ero.2026.100208_bib0044","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s00296-024-05733-y","article-title":"Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study","volume":"44","author":"Bournia","year":"2024","journal-title":"Rheumatol Int."},{"issue":"7","key":"10.1016\/j.ero.2026.100208_bib0045","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00296-023-05316-3","article-title":"Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO","volume":"43","author":"Venetsanopoulou","year":"2023","journal-title":"Rheumatol Int."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0046","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.5562","article-title":"Identification of rheumatoid arthritis in German claims data using different algorithms: validation by cross-sectional patient-reported survey data","volume":"32","author":"Callhoff","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.ero.2026.100208_bib0047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03009748909092611","article-title":"Activity and severity of rheumatoid arthritis in Hannover\/FRG and in one regional referral center","volume":"79","author":"Wasmus","year":"1989","journal-title":"Scand J Rheumatol Suppl."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005331","article-title":"Incidence of rheumatoid arthritis in Austria: a prospective population-based cohort study in a federal province","volume":"11","author":"Puchner","year":"2025","journal-title":"RMD Open."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0049","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-018-4235-7","article-title":"The incidence rate and the early management of rheumatoid arthritis in Slovenia","volume":"38","author":"Je\u0161e","year":"2019","journal-title":"Clin Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00325481.2018.1399774","article-title":"Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study","volume":"130","author":"De Socio","year":"2018","journal-title":"Postgrad Med."},{"issue":"4","key":"10.1016\/j.ero.2026.100208_bib0051","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00296-022-05268-0","article-title":"Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980-2020","volume":"43","author":"Elfving","year":"2023","journal-title":"Rheumatol Int."},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0052","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1136\/annrheumdis-2023-eular.1432","article-title":"The incidence and prevalence of rheumatoid arthritis in Italy in the last decade [abstract AB1628]","volume":"82","author":"Zen","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0053","first-page":"736","article-title":"Rheumatoid arthritis is etting less frequent-results of a nationwide population-based cohort study","volume":"56","author":"Abhishek","year":"2017","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0054","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.semarthrit.2021.08.006","article-title":"Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway","volume":"51","author":"Kerola","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.ero.2026.100208_bib0055","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00296-015-3247-8","article-title":"Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system","volume":"35","author":"\u015aliwczy\u0144ski","year":"2015","journal-title":"Rheumatol Int."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03009742.2021.1997436","article-title":"Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents","volume":"52","author":"Kerola","year":"2023","journal-title":"Scand J Rheumatol."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0057","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/kew228","article-title":"Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology","volume":"55","author":"Dean","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0058","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/03009742.2019.1669704","article-title":"Prevalence of ankylosing spondylitis in Spain: EPISER2016 Study","volume":"49","author":"Quilis","year":"2020","journal-title":"Scand J Rheumatol."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001888","article-title":"Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades","volume":"7","author":"Crossfield","year":"2021","journal-title":"RMD Open."},{"issue":"4","key":"10.1016\/j.ero.2026.100208_bib0060","first-page":"254","article-title":"Psoriatic arthritis and ankylosing spondylitis impact on health-related quality of life and working life: a comparative population-based study","volume":"44","author":"Rodrigues","year":"2019","journal-title":"Acta Reumatol Port."},{"issue":"7","key":"10.1016\/j.ero.2026.100208_bib0061","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3899\/jrheum.180670","article-title":"Burden and disease characteristics of patients with psoriatic arthritis: a population-based cross-sectional study","volume":"46","author":"Tekin","year":"2019","journal-title":"J Rheumatol."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0062","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/keaa448","article-title":"Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database","volume":"60","author":"Pina Vegas","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0063","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5114\/reum.2016.64902","article-title":"Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland","volume":"54","author":"Raciborski","year":"2016","journal-title":"Reumatologia."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0064","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00296-020-04734-x","article-title":"Trends in psoriatic arthritis epidemiology in Poland","volume":"41","author":"T\u0142ustochowicz","year":"2021","journal-title":"Rheumatol Int."},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ard.2025.05.062","article-title":"Increase in Prevalence and Incidence Rates of Psoriatic Arthritis in Catalonia, Spain: A Population-Based Study [abstract OP0038]","volume":"84","author":"G\u00f3mez-Puerta","year":"2025","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234556","article-title":"Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study","volume":"15","author":"Romero P\u00e9rez","year":"2020","journal-title":"PLoS One."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0067","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41584-025-01286-x","article-title":"Global epidemiology of spondyloarthritis","volume":"21","author":"Reveille","year":"2025","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.ero.2026.100208_bib0068","series-title":"Oxford Textbook of Rheumatology","first-page":"941","article-title":"Axial spondyloarthropathies","author":"Sieper","year":"2013"},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0069","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003591","article-title":"Estimated prevalence, incidence and healthcare costs of Sj\u00f6gren\u2019s syndrome in France: a national claims-based study","volume":"10","author":"Seror","year":"2024","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.ero.2026.100208_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105544","article-title":"Prevalence and comorbidities of Sjogren\u2019s syndrome patients in the Community of Madrid: a population-based cross-sectional study","volume":"90","author":"Barrio-Cortes","year":"2023","journal-title":"Joint Bone Spine."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0071","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67462-z","article-title":"Prevalence of Sj\u00f6gren\u2019s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases","volume":"10","author":"Narv\u00e1ez","year":"2020","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/j.ero.2026.100208_bib0072","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1136\/annrheumdis-2017-211206","article-title":"Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece","volume":"76","author":"Gergianaki","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0073","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/art.42775","article-title":"Declining incidence of systemic lupus erythematosus in Norway 1999-2017: data from a population cohort identified by International Classification of Diseases, 10th Revision code and verified by classification","volume":"76","author":"Haukeland","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0074","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000166","article-title":"Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey","volume":"2","author":"Branco","year":"2016","journal-title":"RMD Open."},{"issue":"9","key":"10.1016\/j.ero.2026.100208_bib0075","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/rheumatology\/kez668","article-title":"Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?","volume":"59","author":"Cort\u00e9s Verd\u00fa","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0076","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.ard.2025.06.1839","article-title":"Prevalence and incidence of systemic lupus erythematosus in Catalonia, Spain. A population-based study","volume":"84","author":"G\u00f3mez-Puerta","year":"2025","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100208_bib0077","doi-asserted-by":"crossref","DOI":"10.1177\/14799731221125559","article-title":"Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung disease: a nationwide retrospective cohort study","volume":"19","author":"Knarborg","year":"2022","journal-title":"Chron Respir Dis."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0078","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-020-04720-3","article-title":"Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data","volume":"41","author":"Ciaffi","year":"2021","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.ero.2026.100208_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151978","article-title":"Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study","volume":"53","author":"Westerlind","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/03009742.2023.2217620","article-title":"Systemic sclerosis: changes in the incidence rates in the Finnish population during the years 1999-2018","volume":"53","author":"Kortelainen","year":"2024","journal-title":"Scand J Rheumatol."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0081","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson","year":"2017","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"10.1016\/j.ero.2026.100208_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261983","article-title":"Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: a retrospective study using primary care data","volume":"16","author":"Carey","year":"2021","journal-title":"PLoS One."},{"issue":"suppl 1","key":"10.1016\/j.ero.2026.100208_bib0083","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/annrheumdis-2023-eular.2816","article-title":"Incidence, prevalence & mortality in idiopathic inflammatory myopathies & associated interstitial lung disease in England: a national cohort using routinely collected administrative data [abstract POS1208]","volume":"82","author":"Hannah","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0084","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.42561","article-title":"Refining incidence and characteristics of inflammatory myopathies: a quadruple-source capture-recapture survey using the 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria","volume":"75","author":"Debrut","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ero.2026.100208_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12891-016-1127-3","article-title":"The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population","volume":"17","author":"Yates","year":"2016","journal-title":"BMC Musculoskelet Disord."},{"issue":"12","key":"10.1016\/j.ero.2026.100208_bib0086","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington","year":"2018","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0087","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/rheumatology\/keab269","article-title":"Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate","volume":"61","author":"Stamatis","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ero.2026.100208_bib0088","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","article-title":"Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany","volume":"53","author":"Herlyn","year":"2014","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0089","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2021.01.007","article-title":"Giant cell arteritis: a nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment","volume":"51","author":"Therkildsen","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0090","doi-asserted-by":"crossref","first-page":"rkaf055","DOI":"10.1093\/rap\/rkaf055","article-title":"Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation","volume":"9","author":"Kivitalo","year":"2025","journal-title":"Rheumatol Adv Pract."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0091","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00296-022-05167-4","article-title":"Incidence of giant cell arteritis in six districts of Paris, France (2015-2017)","volume":"42","author":"Gonzalez Chiappe","year":"2022","journal-title":"Rheumatol Int."},{"issue":"9","key":"10.1016\/j.ero.2026.100208_bib0092","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/acr2.11472","article-title":"Whole-country and regional incidences of giant cell arteritis in French continental and overseas territories: a 7-year nationwide database analysis","volume":"4","author":"Guittet","year":"2022","journal-title":"ACR Open Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0093","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kez251","article-title":"Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data","volume":"59","author":"Mahr","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.ero.2026.100208_bib0094","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.semarthrit.2021.06.001","article-title":"Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: a population-based study","volume":"51","author":"Muratore","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.24133","article-title":"Incidence trends and mortality of giant cell arteritis in Southern Norway","volume":"73","author":"Andersen","year":"2021","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ero.2026.100208_bib0096","article-title":"Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020","volume":"10","author":"Skaug","year":"2023","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"10.1016\/j.ero.2026.100208_bib0097","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10067-018-4236-6","article-title":"The incidence of giant cell arteritis in Slovenia","volume":"38","author":"Pucelj","year":"2019","journal-title":"Clin Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0098","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003824","article-title":"Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register","volume":"10","author":"Fern\u00e1ndez-Lozano","year":"2024","journal-title":"RMD Open."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0099","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0100","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005526","article-title":"Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort study","volume":"11","author":"Kilian","year":"2025","journal-title":"RMD Open."},{"issue":"9","key":"10.1016\/j.ero.2026.100208_bib0101","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/rheumatology\/kez597","article-title":"Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway","volume":"59","author":"Nilsen","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.ero.2026.100208_bib0102","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002949","article-title":"Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study","volume":"9","author":"Rathmann","year":"2023","journal-title":"RMD Open."},{"issue":"6 suppl 115","key":"10.1016\/j.ero.2026.100208_bib0103","first-page":"33","article-title":"New insights into Behcet's disease in Ireland: the Midwest cohort study","volume":"36","author":"Adeeb","year":"2018","journal-title":"Clin Exp Rheumatol."},{"issue":"8","key":"10.1016\/j.ero.2026.100208_bib0104","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/rheumatology\/keaf224","article-title":"Incidence and prevalence of Beh\u00e7et\u2019s disease in Oslo, Norway: a two-decade population-based analysis","volume":"64","author":"Lorentsen","year":"2025","journal-title":"Rheumatology (Oxford)."},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0105","first-page":"652","article-title":"Beh\u00e7et disease: a rare systemic vasculitis in Poland","volume":"127","author":"Kanecki","year":"2017","journal-title":"Pol Arch Intern Med"},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0106","first-page":"1991","article-title":"Epidemiology and clinical domains of Beh\u00e7et\u2019s disease in the Cantabria region, Northern Spain","volume":"41","author":"Su\u00e1rez-Amor\u00edn","year":"2023","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.ero.2026.100208_bib0107","series-title":"Presented at the 19th International Conference on Beh\u00e7et\u2019s Disease","article-title":"An update on the epidemiology of Beh\u00e7et\u2019s disease in southern Sweden [abstract P022]","author":"Gisslander","year":"2022"},{"key":"10.1016\/j.ero.2026.100208_bib0108","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20072","article-title":"Beh\u00e7et's syndrome: clinical presentation and prevalence in Switzerland","volume":"149","author":"Villiger","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"10","key":"10.1016\/j.ero.2026.100208_bib0109","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/rheumatology\/keaa010","article-title":"Epidemiology, morbidity and mortality in Beh\u00e7et\u2019s disease: a cohort study using The Health Improvement Network (THIN)","volume":"59","author":"Thomas","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"3","key":"10.1016\/j.ero.2026.100208_bib0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.26444\/aaem\/92702","article-title":"Takayasu\u2019s arteritis: a rare disease in Poland","volume":"25","author":"Kanecki","year":"2018","journal-title":"Ann Agric Environ Med."},{"issue":"6","key":"10.1016\/j.ero.2026.100208_bib0111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250025","article-title":"Takayasu arteritis: prevalence and clinical presentation in Switzerland","volume":"16","author":"Gloor","year":"2021","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.ero.2026.100208_bib0112","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00296-016-3445-z","article-title":"The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey","volume":"36","author":"Saritas","year":"2016","journal-title":"Rheumatol Int."},{"issue":"11","key":"10.1016\/j.ero.2026.100208_bib0113","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"10.1016\/j.ero.2026.100208_bib0114","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3899\/jrheum.121215","article-title":"Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec","volume":"40","author":"Ng","year":"2013","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.ero.2026.100208_bib0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3899\/jrheum.130675","article-title":"Estimating disease prevalence and incidence using administrative data: some assembly required","volume":"40","author":"Ward","year":"2013","journal-title":"J Rheumatol."}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:29:14Z","timestamp":1790342954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708126001072"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100208","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiology of inflammatory rheumatic diseases in Germany in a European context: a systematic review to support workforce planning","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100208"}}